Articles with public access mandates - Duane D. MillerLearn more
Not available anywhere: 9
The role of vitamin D in cancer prevention
RA Ness, DD Miller, LI Wei
Chinese journal of natural medicines 13 (7), 481-497, 2015
Mandates: US National Institutes of Health
Multiple Sclerosis impact on employment and income in New Zealand
JF Pearson, S Alla, G Clarke, DF Mason, T Anderson, A Richardson, ...
Acta Neurologica Scandinavica 136 (3), 223-232, 2017
Mandates: National Institute for Health Research, UK
Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson’s disease brain
M DeCuypere, Y Lu, DD Miller, MS LeDoux
Journal of neurochemistry 107 (5), 1398-1413, 2008
Mandates: US National Institutes of Health
Localization of N‐methyl‐norsalsolinol within rodent and human brain
M DeCuypere, VN Kalabokis, R Hao, D Schroeder, DD Miller, MS LeDoux
Journal of neuroscience research 86 (11), 2543-2552, 2008
Mandates: US National Institutes of Health
Preclinical pharmacokinetics of the radiomitigator KZ-41 in rats
K Zeng, KE Thompson, CS Presley, DD Miller, CR Yates
Xenobiotica 41 (11), 1006-1012, 2011
Mandates: US National Institutes of Health
A novel CCM1 mutation in a 2-year old child: Cerebral and cutaneous manifestations of familial cavernoma
O Sürücü, U Sure, S Stahl, S Gaetzner, D Miller, H Bertalanffy, U Felbor
Monatsschrift Kinderheilkunde 155, 1161-1165, 2007
Mandates: German Research Foundation
Quinic Acid Derivative KZ‐41 Exhibits Radiomitigating Activity in Preclinical Models of Radiation Injury
KE Thompson, K Zeng, CM Wilson, MW Gaber, DD Miller, CR Yates
Drug Development Research 75 (1), 29-36, 2014
Mandates: US National Institutes of Health
Bioisosteric phentolamine analogs as selective human α2-versus α1-adrenoceptor ligands
SA Bavadekar, SS Hong, SII Lee, DD Miller, DR Feller
European journal of pharmacology 590 (1-3), 53-60, 2008
Mandates: US National Institutes of Health
4 Years of X-ray Imaging at 05B1-1 Beamline at BMIT
G Belev, D Miller, N Samadi, MA Webb, TW Wysokinski, N Zhu, ...
World Congress on Medical Physics and Biomedical Engineering, June 7-12 …, 2015
Mandates: Canadian Institutes of Health Research
Available somewhere: 101
An overview of tubulin inhibitors that interact with the colchicine binding site
Y Lu, J Chen, M Xiao, W Li, DD Miller
Pharmaceutical research 29, 2943-2971, 2012
Mandates: US National Institutes of Health
Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, biological evaluation, and structure− activity relationships
Y Lu, CM Li, Z Wang, CR Ross, J Chen, JT Dalton, W Li, DD Miller
Journal of medicinal chemistry 52 (6), 1701-1711, 2009
Mandates: US National Institutes of Health
Tubulin inhibitor-based antibody-drug conjugates for cancer therapy
H Chen, Z Lin, KE Arnst, DD Miller, W Li
Molecules 22 (8), 1281, 2017
Mandates: US National Institutes of Health
Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone
R Leblanc, SC Lee, M David, JC Bordet, DD Norman, R Patil, D Miller, ...
Blood, The Journal of the American Society of Hematology 124 (20), 3141-3150, 2014
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity
AT Slominski, Z Janjetovic, BE Fuller, MA Zmijewski, RC Tuckey, ...
PloS one 5 (3), e9907, 2010
Mandates: US National Institutes of Health
New substituted 4H-chromenes as anticancer agents
SA Patil, J Wang, XS Li, J Chen, TS Jones, A Hosni-Ahmed, R Patil, ...
Bioorganic & medicinal chemistry letters 22 (13), 4458-4461, 2012
Mandates: US National Institutes of Health
Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents
J Chen, Z Wang, CM Li, Y Lu, PK Vaddady, B Meibohm, JT Dalton, ...
Journal of medicinal chemistry 53 (20), 7414-7427, 2010
Mandates: US National Institutes of Health
Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc
RC Tuckey, W Li, JK Zjawiony, MA Zmijewski, MN Nguyen, T Sweatman, ...
The FEBS journal 275 (10), 2585-2596, 2008
Mandates: US National Institutes of Health
20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells
AT Slominski, TK Kim, Z Janjetovic, RC Tuckey, R Bieniek, J Yue, W Li, ...
American Journal of Physiology-Cell Physiology 300 (3), C526-C541, 2011
Mandates: US National Institutes of Health
Controlling cancer through the autotaxin–lysophosphatidic acid receptor axis
M Gotoh, Y Fujiwara, J Yue, J Liu, SC Lee, J Fells, A Uchiyama, ...
Biochemical Society Transactions 40 (1), 31-36, 2012
Mandates: US National Institutes of Health
Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents
J Chen, S Ahn, J Wang, Y Lu, JT Dalton, DD Miller, W Li
Journal of medicinal chemistry 55 (16), 7285-7289, 2012
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program